EDGAR Filing Documents for 0001437749-17-008685

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001437749-17-008685

Filing Date

2017-05-11

Accepted

2017-05-11 08:32:46

Documents

Period of Report

2017-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	snbp20170331_10q.htm	10-Q	637539
2	EXHIBIT 31.1	ex31-1.htm	EX-31.1	15027
3	EXHIBIT 31.2	ex31-2.htm	EX-31.2	15038
4	EXHIBIT 32.1	ex32-1.htm	EX-32.1	5673
5	EXHIBIT 32.2	ex32-2.htm	EX-32.2	5856
	Complete submission text file	0001437749-17-008685.txt		3624099

Data Files

Seq	Description	Document	Type	Size
6	EXHIBIT 101.INS	snbp-20170331.xml	EX-101.INS	690456
7	EXHIBIT 101.SCH	snbp-20170331.xsd	EX-101.SCH	42796
8	EXHIBIT 101.CAL	snbp-20170331_cal.xml	EX-101.CAL	26633
9	EXHIBIT 101.DEF	snbp-20170331_def.xml	EX-101.DEF	274762
10	EXHIBIT 101.LAB	snbp-20170331_lab.xml	EX-101.LAB	235280
11	EXHIBIT 101.PRE	snbp-20170331_pre.xml	EX-101.PRE	294513

Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387

Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196

Sun BioPharma, Inc. (Filer) CIK: 0001029125 (see all company filings)